Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mental dysfunction in Parkinson's disease]

E Růzicka1

  • 1Neurologická klinka 1. LF UK a VFN, Praha.

Casopis Lekaru Ceskych
|April 3, 1996
PubMed
Summary
This summary is machine-generated.

Parkinson's disease often involves mental disturbances, including subcortical dementia in 10-20% of patients. Cognitive deficits, particularly executive dysfunction, are common, linked to complex neurochemical changes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring glymphatic system alterations in iRBD and Parkinson's disease using automated DTI-ALPS analysis.

NPJ Parkinson's disease·2025
Same author

Analysis of striatal connectivity corresponding to striosomes and matrix in de novo Parkinson's disease and isolated REM behavior disorder.

NPJ Parkinson's disease·2024
Same author

Comparative study of the substantia nigra echogenicity and <sup>123</sup>I-Ioflupane SPECT in patients with synucleinopathies with and without REM sleep behavior disorder.

Sleep medicine·2020
Same author

Comment on "pro-saccades predict cognitive decline in Parkinson's disease: ICICLE-PD".

Movement disorders : official journal of the Movement Disorder Society·2020
Same author

Automatic substantia nigra segmentation in neuromelanin-sensitive MRI by deep neural network in patients with prodromal and manifest synucleinopathy.

Physiological research·2020
Same author

Correction to: Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients.

Journal of neural transmission (Vienna, Austria : 1996)·2018
Same journal

The personality of professor Otakar Štark in the context of the development of medical genetics in Czechoslovakia in the years 1950-1990.

Casopis lekaru ceskych·2026
Same journal

Václav Náprstek, MD - a forgotten hero.

Casopis lekaru ceskych·2026
Same journal

Professor Otto Piffl, the First Full Professor of Otology and Rhinology at the German University in Prague, passed away 100 years ago.

Casopis lekaru ceskych·2026
Same journal

Ancient sanctuary of Eileithyia, goddess of childbirth, on the island of Paros (Greece).

Casopis lekaru ceskych·2026
Same journal

European Partnership for Personalised Medicine (EP PerMed).

Casopis lekaru ceskych·2026
Same journal

Periodontitis and type 2 diabetes.

Casopis lekaru ceskych·2026
See all related articles

Area of Science:

  • Neurology
  • Neuroscience
  • Psychiatry

Context:

  • Parkinson's disease (PD) presents with motor symptoms and frequent non-motor disturbances.
  • Cognitive impairment and psychiatric complications are significant aspects of PD.
  • Subcortical dementia affects 10-20% of PD patients, differing from Alzheimer's dementia.

Purpose:

  • To detail the spectrum of cognitive and psychiatric disturbances in Parkinson's disease.
  • To characterize the nature of cognitive deficits, especially executive dysfunction.
  • To explore the underlying pathophysiological mechanisms of cognitive dysfunction in PD.

Summary:

  • Mental disturbances are common in Parkinson's disease (PD), with subcortical dementia occurring in 10-20% of cases.
  • Cognitive impairments include depression, speech deficits, visuospatial and memory problems, and executive dysfunction.

Related Experiment Videos

  • Pathophysiology involves dopaminergic and non-dopaminergic changes at the subcortico-cortical level.

    • Impact:

    • Highlights the prevalence and specific types of cognitive impairment in PD.
    • Provides insight into the differential diagnosis of dementia in PD patients.
    • Informs potential therapeutic strategies targeting neurochemical imbalances in PD.